GSK to seek dismissal of Florida case against heartburn drug Zantac
(Reuters) – British drugmaker GSK said on Friday it would seek a dismissal of an upcoming Zantac case in Florida, where plaintiffs alleged that its discontinued heart burn drug had caused prostate cancer. The move followed a Florida court ruling on Thursday in favour of GSK and other defendants. The ruling excluded testimony from experts…